Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Automated machine-learning framework for predicting drug solubility in supercritical CO<sub>2</sub> for sustainable process development.

Scientific reportsยท2026
Same author

Artificial intelligence-based modeling and validation for prediction of drug delivery capacity and cytotoxicity in design of porous materials.

Frontiers in chemistryยท2026
Same author

Data-driven prediction of lipophilic drug solubility in supercritical CO<sub>2</sub> using an adaptive ensemble learning architecture.

Frontiers in medicineยท2026
Same author

Connecting the dots between phage pharmacokinetics, pharmacodynamics and immune interactions.

Microbial pathogenesisยท2026
Same author

Expired fexofenadine hydrochloride acts as a high-performance sustainable corrosion inhibitor for copper in MSF desalination applications.

Scientific reportsยท2026
Same author

Computational modeling of eticyclidine drug adsorption and detection on c<sub>60</sub> based nanostructures.

Scientific reportsยท2026

Related Experiment Video

Updated: Jul 17, 2026

A Workflow for Lipid Nanoparticle (LNP) Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models (SVEM)
13:54

A Workflow for Lipid Nanoparticle (LNP) Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models (SVEM)

Published on: August 18, 2023

Discovering interpretable drug formulation behavior patterns via a mechanistic-augmented conditional variational

El-Sayed Khafagy1, Amr Selim Abu Lila2, Ahmed Al Saqr1

  • 1Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, 11942, Al-Kharj, Saudi Arabia.

Scientific Reports
|July 15, 2026
PubMed
Summary

Latent generative modeling reveals structured patterns in drug formulation data, moving beyond simple prediction. This approach helps understand complex formulation behaviors and generate new hypotheses for data-driven research.

Keywords:
Drug formulation behaviourLatent space representationParticle sizeSolubility modelling

Related Experiment Videos

Last Updated: Jul 17, 2026

A Workflow for Lipid Nanoparticle (LNP) Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models (SVEM)
13:54

A Workflow for Lipid Nanoparticle (LNP) Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models (SVEM)

Published on: August 18, 2023

Area of Science:

  • Pharmaceutical Sciences
  • Computational Chemistry
  • Materials Science

Background:

  • Drug formulation development involves complex interactions between composition, processing, and outcomes like solubility and particle size.
  • Current methods often rely on trial-and-error, limiting a deep understanding of these intricate relationships.
  • The potential for extracting structured, interpretable patterns from experimental formulation data remains largely unexplored.

Purpose of the Study:

  • To investigate if latent generative modeling can organize formulation knowledge continuously and in a regime-aware manner.
  • To determine if experimental formulation data contains patterns beyond mere predictive capabilities.
  • To explore a novel approach for understanding complex drug formulation behavior.

Main Methods:

  • Systematic mining of 114 niosome formulation samples from 17 publications using the PRISMA framework.
  • Utilizing a mechanistic-augmented conditional variational autoencoder to model drug encapsulation efficiency and particle size.
  • Employing 11 drug, formulation, and processing variables as model inputs.

Main Results:

  • The developed latent space exhibited a continuous structure with overlapping regimes and smooth transitions.
  • Feature-response relationships were found to be context-dependent within the latent landscape.
  • The model successfully structurized formulation knowledge, revealing interpretable behaviors.

Conclusions:

  • Formulation behavior can be conceptualized as a structured latent landscape.
  • Latent generative modeling offers a powerful tool for regime-aware analysis in drug formulation.
  • This approach facilitates hypothesis generation for data-driven formulation research.